Cadence Bank NA grew its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,589 shares of the pharmacy operator’s stock after purchasing an additional 1,579 shares during the period. Walgreens Boots Alliance comprises approximately 0.9% of Cadence Bank NA’s holdings, making the stock its 29th biggest holding. Cadence Bank NA’s holdings in Walgreens Boots Alliance were worth $2,303,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of the company. BlueMountain Capital Management LLC acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth about $103,000. CSat Investment Advisory L.P. acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth about $104,000. Squar Milner Financial Services LLC acquired a new position in Walgreens Boots Alliance during the 2nd quarter worth about $106,000. Asset Dedication LLC lifted its position in Walgreens Boots Alliance by 204.6% during the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock worth $115,000 after buying an additional 1,060 shares in the last quarter. Finally, Kaizen Advisory LLC lifted its position in Walgreens Boots Alliance by 128.6% during the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,083 shares in the last quarter. Institutional investors own 64.57% of the company’s stock.
In related news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at approximately $6,386,356.52. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 1st. The stock was sold at an average price of $79.48, for a total value of $217,457.28. Following the sale, the director now directly owns 8,207 shares of the company’s stock, valued at $652,292.36. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 66,706 shares of company stock valued at $5,268,584. 14.80% of the stock is currently owned by company insiders.
Shares of WBA stock opened at $82.39 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. The stock has a market capitalization of $76.50 billion, a PE ratio of 13.69, a P/E/G ratio of 1.28 and a beta of 0.74. Walgreens Boots Alliance Inc has a one year low of $59.07 and a one year high of $83.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.03. The company had revenue of $33.44 billion during the quarter, compared to analysts’ expectations of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. As a group, sell-side analysts expect that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be paid a $0.44 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.14%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 29.24%.
Several brokerages have weighed in on WBA. TheStreet raised Walgreens Boots Alliance from a “c+” rating to a “b” rating in a report on Wednesday, September 12th. BidaskClub raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a report on Wednesday, September 12th. Loop Capital boosted their price objective on Walgreens Boots Alliance from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Friday, October 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a report on Tuesday, September 25th. Finally, Barclays boosted their price objective on Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an “equal weight” rating in a report on Friday, October 12th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $78.22.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/11/10/walgreens-boots-alliance-inc-wba-stake-raised-by-cadence-bank-na.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Read More: 52-Week High/Low
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.